Bao S - Search Results

1

Leveraging pharmacovigilance data to predict population-scale toxicity profiles of checkpoint inhibitor immunotherapy.

Yan D, Bao S, Zhang Z, Sun J, Zhou M. Yan D, et al. Among authors: bao s. Nat Comput Sci. 2024 Dec 23. doi: 10.1038/s43588-024-00748-8. Online ahead of print. Nat Comput Sci. 2024. PMID: 39715829

2

Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer.

Sun J, Zhang Z, Bao S, Yan C, Hou P, Wu N, Su J, Xu L, Zhou M. Sun J, et al. Among authors: bao s. J Immunother Cancer. 2020 Feb;8(1):e000110. doi: 10.1136/jitc-2019-000110. J Immunother Cancer. 2020. PMID: 32041817 Free PMC article.

3

Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes.

Zhang Z, Yan C, Li K, Bao S, Li L, Chen L, Zhao J, Sun J, Zhou M. Zhang Z, et al. Among authors: bao s. NPJ Genom Med. 2021 Jun 17;6(1):52. doi: 10.1038/s41525-021-00215-7. NPJ Genom Med. 2021. PMID: 34140519 Free PMC article.

4

The transcriptional landscape and diagnostic potential of long non-coding RNAs in esophageal squamous cell carcinoma.

Zhou M, Bao S, Gong T, Wang Q, Sun J, Li J, Lu M, Sun W, Su J, Chen H, Liu Z. Zhou M, et al. Among authors: bao s. Nat Commun. 2023 Jun 26;14(1):3799. doi: 10.1038/s41467-023-39530-1. Nat Commun. 2023. PMID: 37365153 Free PMC article.

5

A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.

Zhou M, Zhang Z, Zhao H, Bao S, Sun J. Zhou M, et al. Among authors: bao s. BMC Cancer. 2018 Jan 5;18(1):39. doi: 10.1186/s12885-017-3983-0. BMC Cancer. 2018. PMID: 29304762 Free PMC article.

6

Integrative analysis from multi-centre studies identifies a function-derived personalized multi-gene signature of outcome in colorectal cancer.

Sun J, Zhao H, Lin S, Bao S, Zhang Y, Su J, Zhou M. Sun J, et al. Among authors: bao s. J Cell Mol Med. 2019 Aug;23(8):5270-5281. doi: 10.1111/jcmm.14403. Epub 2019 May 29. J Cell Mol Med. 2019. PMID: 31140730 Free PMC article.

7

Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.

Bao S, Zhao H, Yuan J, Fan D, Zhang Z, Su J, Zhou M. Bao S, et al. Brief Bioinform. 2020 Sep 25;21(5):1742-1755. doi: 10.1093/bib/bbz118. Brief Bioinform. 2020. PMID: 31665214

8

Computational principles and practice for decoding immune contexture in the tumor microenvironment.

Zhang Z, Bao S, Yan C, Hou P, Zhou M, Sun J. Zhang Z, et al. Among authors: bao s. Brief Bioinform. 2021 May 20;22(3):bbaa075. doi: 10.1093/bib/bbaa075. Brief Bioinform. 2021. PMID: 32496512

9

Computational Methods and Applications for Identifying Disease-Associated lncRNAs as Potential Biomarkers and Therapeutic Targets.

Yan C, Zhang Z, Bao S, Hou P, Zhou M, Xu C, Sun J. Yan C, et al. Among authors: bao s. Mol Ther Nucleic Acids. 2020 Sep 4;21:156-171. doi: 10.1016/j.omtn.2020.05.018. Epub 2020 May 21. Mol Ther Nucleic Acids. 2020. PMID: 32585624 Free PMC article.

10

Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.

Bao S, Hu T, Liu J, Su J, Sun J, Ming Y, Li J, Wu N, Chen H, Zhou M. Bao S, et al. J Nanobiotechnology. 2021 Jan 12;19(1):22. doi: 10.1186/s12951-020-00767-3. J Nanobiotechnology. 2021. PMID: 33436002 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,700 results

Search Page

Filters